A detailed history of Janus Henderson Group PLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 58,977 shares of IONS stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,977
Previous 58,977 -0.0%
Holding current value
$2.15 Million
Previous $2.81 Million 15.94%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $26,973 - $35,298
-740 Reduced 1.24%
58,977 $2.81 Million
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $588 - $749
14 Added 0.02%
59,717 $2.59 Million
Q4 2023

Feb 14, 2024

SELL
$43.39 - $51.63 $4,469 - $5,317
-103 Reduced 0.17%
59,703 $3.02 Million
Q3 2023

Nov 14, 2023

BUY
$38.5 - $47.13 $154 - $188
4 Added 0.01%
59,806 $2.71 Million
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $1,979 - $2,469
-57 Reduced 0.1%
59,802 $2.45 Million
Q1 2023

May 15, 2023

BUY
$33.58 - $41.2 $206,080 - $252,844
6,137 Added 11.42%
59,859 $2.14 Million
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $1.14 Million - $1.42 Million
30,582 Added 132.16%
53,722 $2.03 Million
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $2,448 - $3,260
-67 Reduced 0.29%
23,140 $1.02 Million
Q2 2022

Aug 15, 2022

SELL
$31.71 - $43.0 $79,782 - $108,188
-2,516 Reduced 9.78%
23,207 $858,000
Q1 2022

May 16, 2022

BUY
$29.88 - $37.04 $209 - $259
7 Added 0.03%
25,723 $953,000
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $306,500 - $420,076
11,968 Added 87.05%
25,716 $783,000
Q3 2021

Nov 16, 2021

BUY
$33.54 - $40.55 $461,107 - $557,481
13,748 New
13,748 $461,000
Q2 2021

Aug 16, 2021

SELL
$34.54 - $47.25 $2.65 Million - $3.62 Million
-76,644 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$42.51 - $63.78 $1.11 Million - $1.66 Million
26,018 Added 51.39%
76,644 $3.45 Million
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $455,400 - $605,894
-10,053 Reduced 16.57%
50,626 $2.86 Million
Q3 2020

Nov 16, 2020

SELL
$47.45 - $62.95 $419,837 - $556,981
-8,848 Reduced 12.73%
60,679 $2.88 Million
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $1.04 Million - $1.36 Million
22,253 Added 47.07%
69,527 $4.1 Million
Q1 2020

May 14, 2020

SELL
$41.6 - $63.4 $6.42 Million - $9.79 Million
-154,438 Reduced 76.56%
47,274 $2.24 Million
Q4 2019

Feb 18, 2020

SELL
$53.85 - $65.27 $20.5 Million - $24.9 Million
-380,819 Reduced 65.37%
201,712 $12.2 Million
Q3 2019

Nov 14, 2019

BUY
$59.06 - $72.15 $16.2 Million - $19.8 Million
274,852 Added 89.33%
582,531 $34.9 Million
Q2 2019

Jul 31, 2019

BUY
$62.09 - $86.14 $13.1 Million - $18.2 Million
211,161 Added 218.78%
307,679 $19.8 Million
Q1 2019

Apr 30, 2019

BUY
$52.92 - $81.17 $4.48 Million - $6.87 Million
84,587 Added 708.97%
96,518 $7.83 Million
Q4 2018

Feb 06, 2019

BUY
$43.37 - $59.54 $517,447 - $710,371
11,931 New
11,931 $645,000
Q2 2018

Aug 10, 2018

SELL
$40.53 - $50.7 $579,579 - $725,010
-14,300 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$44.08 - $55.05 $630,344 - $787,215
14,300 New
14,300 $630,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.